LUFX_LUTLO
ID LUFX_LUTLO Reviewed; 301 AA.
AC Q5WPU8;
DT 03-AUG-2022, integrated into UniProtKB/Swiss-Prot.
DT 23-NOV-2004, sequence version 1.
DT 03-AUG-2022, entry version 16.
DE RecName: Full=Lufaxin {ECO:0000303|PubMed:22796577};
DE AltName: Full=32.4 kDa salivary protein {ECO:0000312|EMBL:AAS05319.1};
DE AltName: Full=Lutzomyia longipalpis FXa inhibitor {ECO:0000303|PubMed:22796577};
DE Flags: Precursor;
OS Lutzomyia longipalpis (Sand fly).
OC Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota;
OC Neoptera; Endopterygota; Diptera; Nematocera; Psychodoidea; Psychodidae;
OC Lutzomyia; Lutzomyia.
OX NCBI_TaxID=7200;
RN [1] {ECO:0000312|EMBL:AAS05319.1}
RP NUCLEOTIDE SEQUENCE [MRNA].
RC TISSUE=Salivary gland;
RX PubMed=15371479; DOI=10.1242/jeb.01185;
RA Valenzuela J.G., Garfield M., Rowton E.D., Pham V.M.;
RT "Identification of the most abundant secreted proteins from the salivary
RT glands of the sand fly Lutzomyia longipalpis, vector of Leishmania
RT chagasi.";
RL J. Exp. Biol. 207:3717-3729(2004).
RN [2]
RP FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, RECOMBINANT PROTEIN,
RP BIOASSAY, AND PROBABLE GLYCOSYLATION AT ASN-262.
RX PubMed=22796577; DOI=10.1161/atvbaha.112.253906;
RA Collin N., Assumpcao T.C., Mizurini D.M., Gilmore D.C., Dutra-Oliveira A.,
RA Kotsyfakis M., Sa-Nunes A., Teixeira C., Ribeiro J.M., Monteiro R.Q.,
RA Valenzuela J.G., Francischetti I.M.;
RT "Lufaxin, a novel factor Xa inhibitor from the salivary gland of the sand
RT fly Lutzomyia longipalpis blocks protease-activated receptor 2 activation
RT and inhibits inflammation and thrombosis in vivo.";
RL Arterioscler. Thromb. Vasc. Biol. 32:2185-2198(2012).
RN [3]
RP FUNCTION, SUBUNIT, AND RECOMBINANT EXPRESSION.
RX PubMed=28912782; DOI=10.3389/fimmu.2017.01065;
RA Mendes-Sousa A.F., do Vale V.F., Silva N.C.S., Guimaraes-Costa A.B.,
RA Pereira M.H., Sant'Anna M.R.V., Oliveira F., Kamhawi S., Ribeiro J.M.C.,
RA Andersen J.F., Valenzuela J.G., Araujo R.N.;
RT "The sand fly salivary protein lufaxin inhibits the early steps of the
RT alternative pathway of complement by direct binding to the proconvertase
RT C3b-B.";
RL Front. Immunol. 8:1065-1065(2017).
CC -!- FUNCTION: Sand fly salivary protein with antithrombotic, and anti-
CC complement (alternative pathway) activities (PubMed:22796577,
CC PubMed:28912782). Is a slow, tight, non-competitive, and reversible
CC inhibitor of factor Xa (FXa, F10) (PubMed:22796577). Is specific for
CC FXa (Kd=3.86 nM) and does not interact with non-activated FX, or all
CC other enzymes tested (PubMed:22796577). In addition, it blocks
CC prothrombinase and increases both prothrombin time and activated
CC partial thromboplastin time (PubMed:22796577). It also prevents
CC protease-activated receptor 2 (F2RL1, PAR2) activation by FXa
CC (PubMed:22796577). In vivo, it abrogates edema formation triggered by
CC injection of FXa in the paw of mice (PubMed:22796577). Moreover, it
CC prevents FeCl3-induced carotid artery thrombus formation and prolongs
CC activated partial thromboplastin time ex vivo, implying that it works
CC as an anticoagulant in vivo (PubMed:22796577). It also inhibits the
CC early steps of the alternative pathway of complement by direct binding
CC to the proconvertase C3b-B complex, by inhibiting activation of factor
CC B and consequently the formation of the C3 convertase
CC (PubMed:28912782). {ECO:0000269|PubMed:22796577,
CC ECO:0000269|PubMed:28912782}.
CC -!- SUBUNIT: Interacts with factor Xa (PubMed:22796577). Interacts with
CC complement proconvertase C3b-B complex (PubMed:28912782).
CC {ECO:0000269|PubMed:22796577, ECO:0000269|PubMed:28912782}.
CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:22796577}.
CC -!- TISSUE SPECIFICITY: Expressed in salivary glands.
CC {ECO:0000269|PubMed:22796577}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AY445936; AAS05319.1; -; mRNA.
DR VEuPathDB; VectorBase:LLOJ001514; -.
DR Proteomes; UP000092461; Unplaced.
PE 1: Evidence at protein level;
KW Blood coagulation cascade inhibiting toxin;
KW Complement system impairing toxin; Glycoprotein;
KW Hemostasis impairing toxin; Secreted; Signal; Toxin.
FT SIGNAL 1..23
FT /evidence="ECO:0000255"
FT CHAIN 24..301
FT /note="Lufaxin"
FT /id="PRO_5004263472"
FT CARBOHYD 262
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00498,
FT ECO:0000305|PubMed:22796577"
SQ SEQUENCE 301 AA; 34951 MW; F098EAFE12FB1129 CRC64;
MNSINFLSIV GLISFGFIVA VKCDGDEYFI GKYKEKDETL FFASYGLKRD PCQIVLGYKC
SNNQTHFVLN FKTNKKSCIS AIKLTSYPKI NQNSDLTKNL YCQTGGIGTD NCKLVFKKRK
RQIAANIEIY GIPAKKCSFK DRYIGADPLH VDSYGLPYQF DQEHGWNVER YNIFKDTRFS
TEVFYHKNGL FNTQITYLAE EDSFSEAREI TAKDIKKKFS IILPNEEYKR ISFLDVYWFQ
ETMRKKPKYP YIHYNGECSN ENKTCELVFD TDELMTYALV KVFTNPESDG SRLKEEDLGR
G